Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Unlimited Bio

Mentioned in 1 analyzed podcast episode across 1 show

Episode Mentions

MIT Technology Review Narrated

MIT Technology Review Narrated · Apr 15, 2026

This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”

Biotech company developing VEGF and follistatin gene therapies for muscle growth and longevity, operating in Prospera with planned clinical trials starting January 2026

Gene therapy regulation and special economic zonesVEGF (vascular endothelial growth factor) therapy safety and efficacyFollistatin gene therapy for muscle growth
View Analysis